ND5
General Information
DCTPep ID DCTPep01110
Peptide Name ND5
Sequence GLFDRVKKRKSLF
Sequence Length 13
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Cancer therapy related peptides
Activity Information
Cell Line | Disease | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|
Hep-G2 | Hepatoblastoma; Hepatoblastoma | IC50>256 µg/mL | MTT assay | 24h | 1 |
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Vero: IC50>256 µg/mL; THLE-3: IC50>256 µg/mL
Target Not available
Affinity Not available
Mechanism Not available
Structure Information
PDB ID Not available
Predicted Structure DCTPep01110
(Please note that there is the predicted structure, predicted by AlphaFold)
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C74H124N22O17
Absent amino acids ACEHIMNPQTWY
Theoretical pI 11.10
Acidic residues 1
Basic residues 5
Polar residues 2
Molecular weight (Average) 1593.94
Molecular weight (Monoisotopic) 1592.95
Common amino acids K
Net charge 4
Instability index (II) 35.78
Aliphatic index 82.31
Grand average of hydropathicity (GRAVY) -0.615
Half Life
30 hours (mammalian reticulocytes, in vitro).
>20 hours (yeast, in vivo).
>10 hours (Escherichia coli, in vivo).
Extinction coefficients
Should not be visible by UV spectrophotometry.
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Hybrid Anticancer Peptides DN1 and DN4 Exert Selective Cytotoxicity Against Hepatocellular Carcinoma Cells by Inducing Both Intrinsic and Extrinsic Apoptotic Pathways
Doi 10.1007/s10989-021-10288-8
Year 2021
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available